insights_auto
Outlook: 23.5% bullish·58.8% bearish
Go to analysischevron_right
AVBP:NASDAQ
Arrivent Biopharma Inc
$16.73
arrow_upward
+0.12%(+0.020) 1D
$16.57
arrow_downward
-0.96% (-0.16)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 11 analysts giving stock ratings to AVBP in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for AVBP in the last 3 months.
Highest
Current $16.73
$50.00 (+198.86%)
Average
$25.82 (+54.33%)
Lowest
$15.00 (-10.34%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Robert Burns H.C. Wainwright | Buy | Reiterated | $27.00 | +61.4% | 10/08/2026 |
Michael Schmidt Guggenheim | Buy | Reiterated | $18.00 | +7.6% | 10/06/2026 |
Yigal Nochomovitz Citi | Buy | Maintained | $20.00 | +19.5% | 10/07/2026 |
Jeet Mukherjee BTIG | Buy | Reiterated | $29.00 | +73.3% | 10/06/2026 |
Kaveri Pohlman Clear Street | Buy | Maintained | $22.00 | +31.5% | 10/06/2026 |
Boris Peaker JonesTrading | Buy | Reiterated | $22.00 | +31.5% | 10/06/2026 |
Supawat Thongthip Truist Financial | Buy | Maintained | $18.00 | +7.6% | 10/06/2026 |
Kelly Shi Jefferies | Buy | Maintained | $18.00 | +7.6% | 10/06/2026 |
Sam Slutsky LifeSci Capital | Buy | Maintained | $15.00 | -10.3% | 10/06/2026 |
Asthika Goonewardene Leerink Partners | Buy | Maintained | $45.00 | +169% | 08/13/2026 |
Jeff Jones Oppenheimer | Buy | Maintained | $50.00 | +198.9% | 08/13/2026 |
Mayank Mamtani B. Riley Securities | Buy | Maintained | $45.00 | +169% | 05/29/2026 |
Soumit Roy JonesTrading | Buy | Maintained | $45.00 | +169% | 04/06/2026 |